As the COVID-19 pandemic approaches its second anniversary in North America, the medical industry looks much different than it did just two years ago. Health and safety protocols have changed drastically, economies are still shifting and political tensions have heightened as a result of restrictions put in place to manage the virus. The pandemic has […]

Massachusetts General Hospital is preparing to trial Tonix Pharmaceuticals’ nasally delivered potentiated oxytocin TNX-1900 in the treatment of binge eating disorder. Tonix is developing TNX-1900 as a treatment of chronic migraine, with a phase 2 clinical trial set to start in the indication in the second half of the year, but the delivery of the human […]

Oculis has gained exclusive global rights to neuroprotective drug candidate for glaucoma through a licensing agreement with Accure Therapeutics. Oculis, a global ophthalmology company, announced on March 2, 2022 that it has formed a licensing agreement with Accure Therapeutics, a private translational neuroscience R&D company, granting Oculis exclusive global rights to develop and commercialize ACT-01, […]